Business Context and Reporting Period
This Form 8-K filing by Aclarion, Inc. (ACON) was submitted on October 11, 2024, reporting events occurring on October 8, 2024. The Company is an emerging growth company incorporated in Delaware with principal executive offices in Broomfield, Colorado. Its common stock and warrants trade on the Nasdaq Stock Market under the symbols ACON and ACONW, respectively.
Key Financial Metrics
The filing does not provide current revenue, profit, cash flow, or margin data. However, it references the Company's most recent quarterly report (Form 10-Q for the period ended June 30, 2024), which reported stockholders' equity of $1,642,177. This figure is below the Nasdaq Capital Market requirement of $2.5 million.
Material Changes and Listing Status
The Company faces two critical delisting risks from Nasdaq:
- Minimum Bid Price Non-Compliance: On October 8, 2024, the Company received notice that it failed to regain compliance with the $1.00 minimum bid price requirement (Rule 5550(a)(2)) by the October 7, 2024 deadline. This follows an initial notice received in April 2024.
- Stockholders' Equity Non-Compliance: On August 22, 2024, the Company received notice of non-compliance with the $2.5 million minimum stockholders' equity requirement (Rule 5550(b)(1)).
On October 10, 2024, the Company presented a compliance plan to a Nasdaq hearing panel addressing both issues. Trading of the Company's common stock remains stayed pending the panel's written decision.
Outlook, Management Commentary, and Risks
Management intends to implement a reverse stock split to address the bid price requirement. On September 23, 2024, stockholders approved a proposal granting the board discretionary authority to effect a reverse stock split at a ratio between 1-for-5 and 1-for-50 within one year. The Company states it intends to take all reasonable measures to regain compliance and remain listed on Nasdaq. The primary risk is the potential delisting of the Company's securities if the hearing panel rejects the compliance plan or if the Company fails to meet future deadlines.
Investor Verification Checklist
- Verify the outcome of the Nasdaq hearing panel decision scheduled to be issued following the October 10, 2024 hearing.
- Confirm the specific reverse stock split ratio selected by the board of directors and the expected implementation date.
- Review the Company's latest Form 10-Q or 10-K to assess the current stockholders' equity position relative to the $2.5 million threshold.
- Monitor trading status on Nasdaq for any suspension notices pending the hearing panel's final ruling.